Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK

OBJECTIVE: With healthcare systems under increasing financial pressure from costs associated with diabetes care, it is important to assess which treatments provide clinical benefits and represent best value. This study evaluated the annual costs of insulin degludec (degludec) versus insulin detemir...

Descripción completa

Detalles Bibliográficos
Autores principales: Thalange, Nandu, Gundgaard, Jens, Parekh, Witesh, Tutkunkardas, Deniz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Clinical care education/Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731813/
https://www.ncbi.nlm.nih.gov/pubmed/31543973
http://dx.doi.org/10.1136/bmjdrc-2019-000664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731813/
https://www.ncbi.nlm.nih.gov/pubmed/31543973
http://dx.doi.org/10.1136/bmjdrc-2019-000664

Ejemplares similares